Spepharm - SAVENE - Ownership and Business Overview

Life ScienceCompany

Spepharm - SAVENE Ownership

Who owns Spepharm - SAVENE?

Spepharm - SAVENE is owned by Clinigen Group. It was acquired on March 31, 2014.

Spepharm - SAVENE Business Overview

Where is Spepharm - SAVENE headquartered?

Spepharm - SAVENE is headquartered in Switzerland.

What sector is Spepharm - SAVENE in?

Spepharm - SAVENE is a life science company.

Life Science M&A Summary in 2014

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.

Join Mergr to view all 237 acquisitions of life science companies in 2014, including 22 acquisitions by private equity firms, and 215 by strategics.

Spepharm - SAVENE


Switzerland,

Spepharm - SAVENE is a powder and diluent that are made up into a solution for infusion. It contains the active substance dexrazoxane. SAVENE is used to treat extravasation of anthracyclines in adults.


 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Spepharm - SAVENE

Life Science Companies , Switzerland Companies